Nurix Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
NRIX on Nasdaq
Location
1700 Owens Street, Suite 205, San Francisco, CA

Insiders trading volume in the past year

Nurix Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures III, L.P. 10%+ Owner $35.1M May 6, 2021
Column Group L P 10%+ Owner $14.4M May 7, 2021
Gwenn Hansen Chief Scientific Officer $1.84M -$251K -12% Feb 11, 2025
Christine Ring Chief Legal Officer $1.37M -$1.84M -57.4% Feb 11, 2025
Hans van Houte Chief Financial Officer $1.21M -$1.38M -53.2% Mar 3, 2025
Pierre Beaurang Chief Business Officer $1.21M Aug 10, 2021
Stefani Wolff EVP and COO $146K Apr 30, 2023
Lori Anne Kunkel Director $0 Jul 17, 2024
Leon Chen Director May 6, 2021
Arthur T. Sands President, CEO, Director Feb 11, 2025
Anil Kapur Director Oct 15, 2024
Edward C. Saltzman Director May 20, 2024
Roy D. Baynes Director Mar 11, 2025
Clay B. Siegall Director May 5, 2022
Judith A. Reinsdorf Director May 20, 2024
Julia P. Gregory Director May 20, 2024
Paul M. Silva Director May 20, 2024
Jeffrey K. Tong Director, 10%+ Owner May 6, 2021
David L. Lacey Director May 20, 2024

Recent Insider Transactions by Companies or Individuals for Nurix Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.